Vascular Disease Topics
The On-Topic Netowork

Vascular Disease > Heart Failure


Heart Failure
Heart Failure
Heart Failure
Heart Failure
Heart Failure

The following information is about Heart Failure.

Heart Failure Defined

A chronic, progressive condition in which the heart gradually loses it ability to pump blood; as a result, the body’s organs and tissue fail to receive sufficient oxygen.

This definition is in context to Vascular Disease. See more contextual defintions for Heart Failure.


Navigation: [ 1 2 Next ]

One-stop cardiac health plan begins Sept. 16

Published September 7, 2008, 9:11 pm, The Post and Courier

An MUSC program offering a one-stop approach to cardiac health will begin accepting patients Sept. 16. The medical center's new program is made possible by a $1 million gift from Charleston residents Beverly and Wally Seinsheimer.

Full Story


All bets are off

Published September 7, 2008, 3:45 pm, The Maitland Mercury

Revelations of the NSW Government’s dire finances has cast shadows over major projects already promised to the city.

Full Story


Memorial CEO's recipe for fresh ideas :Innovation Cafe encourages learning from failure as well as success

Published September 4, 2008, 4:05 am, South Bend Tribune

SOUTH BEND -- Hungry visitors to Memorial Hospital here sometimes stop by the Innovation Cafe, lured by the outdoor patio with white metal tables and chairs.

Full Story


ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer

Published September 3, 2008, 9:24 am, Centre Daily Times

ImClone Systems Incorporated (NASDAQ: IMCL) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) to broaden the use of ERBITUX(R) (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). The application, submitted on August 29, 2008, was prepared in conjunction ...

Full Story


ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer

Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance

NEW YORK----ImClone Systems Incorporated today announced that it has submitted an application to the U.S. Food and Drug Administration to broaden the use of ERBITUX® to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck .

Full Story


Chrysalin (Rusalatide Acetate, TP508) Pre-Clinical Results Show Significant Beneficial Effect in Chronic Heart Disease

Published September 3, 2008, 6:00 am, GlobeNewswire via Yahoo! Finance

TEMPE, Ariz., Sept. 3, 2008 -- OrthoLogic Corp. announced today the publication of positive results from a pre-clinical study of Chrysalin in a model of chronic myocardial ischemia.

Full Story


DES in diabetic patients

Published September 2, 2008, 6:24 am, EurekAlert!

Diabetes is increasingly viewed as a coronary artery disease equivalent. Patients with diabetes mellitus have an increased risk when undergoing percutaneous coronary interventions. Need for studies specifically targeting diabetic patients.

Full Story


DES In Diabetic Patients

Published September 2, 2008, 3:10 am, Medical News Today

The issue of using or not using DES in patients with diabetes will be debated between Professor Wijns, who discourages DES and Professor Silber, who feels that they should be used. Diabetes is increasingly viewed as a coronary artery disease equivalent.

Full Story


New Molecular Imaging Techniques Aim At Detection Of Earliest Steps Of Disease Development And Therapy Response

Published September 1, 2008, 9:09 am, Medical News Today

An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level.

Full Story


Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ...

Published September 1, 2008, 6:09 am, Medical News Today

The results of the TRANSCEND® trial demonstrate that Micardis® 80mg (telmisartan) reduces the risk of cardiovascular death, myocardial infarction/heart attack and stroke in high-risk cardiovascular patients by 13% compared with those patients already receiving best standard of care (p=0.

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Vascular Disease > Heart Failure news? Try our new "Heart Failure News Focus" area.

Off-site Heart Failure Links, User Submitted

The following links have been collected through user bookmark submission in the Heart Failure category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Sat Sep 6

Fri Sep 5

Sun Aug 31

Tue Aug 26

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Heart Failure. If you would like to find related tags we recommend Tag Patterns > Heart Failure

Off-site Heart Failure Research Links

If you still need additional information on Heart Failure then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Vascular Disease

If you know the Vascular Disease Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Vascular-Disease.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a